Clinical trial
2NN & CHARM Long-Term Follow-up Study
NCT00127972 · International Antiviral Therapy Evaluation Center, Other · Completed
Key facts
| NCT number | NCT00127972 |
|---|---|
| Title | 2NN & CHARM Long-Term Follow-up Study |
| Official title | A Retrospective Study to Compare the 3-Year Antiviral Efficacy of Nevirapine and Efavirenz in Combination With D4t and 3tc in 2NN Patients and of Trizivir Versus Trizivir Plus Nevirapine in CHARM Patients |
| Lead sponsor | International Antiviral Therapy Evaluation Center, Other |
| Collaborators | Boehringer Ingelheim Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | stavudine, lamivudine, nevirapine, efavirenz, trizivir |
| Enrollment | 763 |
| Start date | Feb 1, 2004 |
| Completion | Apr 1, 2007 |
| First posted | Aug 9, 2005 |
| Last update posted | Apr 30, 2007 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: